Healthcare fraud: A look back at a pivotal year

The word fraud framed by other words
From a healthcare fraud enforcement perspective, 2016 was nothing short of a dynamic year. (Getty/Devonyu)

From a healthcare fraud enforcement perspective, 2016 was nothing short of a dynamic year. 

It was punctuated by the arrival of several important trends within the addiction treatment, post-acute care and compound pharmaceutical industries.

It also featured a Supreme Court ruling on a False Claims Act legal theory, and a changing enforcement landscape in the aftermath of the Yates memo.

As 2016 comes to a close, let's look back at some of the fraud trends that emerged—or in some cases intensified—over the past 12 months.

Suggested Articles

There could be imminent shortages of antimalarial drugs and antibiotics that are critical to providing care for COVID-19 patients.

UnitedHealthcare is the latest big-name insurer to waive members’ cost-sharing for COVID-19 treatments. 

Healthcare leaders say the pandemic could prove to be the tipping point for digital health tools that can help manage patients outside hospitals.